Genotype-dependent tumor regression in Marek's disease mediated at the level of tumor immunity

Cancer Microenvironment

Volumn 2, Issue 1, 2009, Pages 23-31

  Kumar, Shyamesh ^a,b   Buza, Joram J ^c   Burgess, Shane C ^a,b  

^a Department of Basic Sciences   (United States)

^b MISSISSIPPI STATE UNIVERSITY   (United States)

^c PURDUE UNIVERSITY   (United States)

Author keywords

Animal model; Gene ontology; Herpesvirus; Lymphoma; Microenvironment; Regulatory T cell

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 83; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 18 BINDING PROTEIN; INTERLEUKIN 2; INTERLEUKIN 4; MESSENGER RNA; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIRD DISEASE; CELL TRANSFORMATION; CHICKEN; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EXPERIMENTAL MODEL; GENE EXPRESSION; GENOTYPE; LYMPHOMA; MAJOR HISTOCOMPATIBILITY COMPLEX; MARDIVIRUS; MICROENVIRONMENT; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TH1 CELL; TH2 CELL; TUMOR IMMUNITY; TUMOR REGRESSION;

EID: 73449095218     PISSN: 18752292     EISSN: 18752284     Source Type: Journal    
DOI: 10.1007/s12307-008-0018-z     Document Type: Article

References (47)

1. A Jemal R Siegel E Ward, et al. 2007 Cancer statistics, 2007 CA Cancer J Clin 57 43 66 10.3322/canjclin.57.1.43 17237035
2. Institute NC (2007) The NCI strategic plan for leading the nation to eliminate the suffering and death due to cancer. Available via: http://strategicplan.nci.nih.gov/pdf/nci-2007
3. SC Burgess JR Young BJ Baaten, et al. 2004 Marek's disease is a natural model for lymphomas overexpressing Hodgkin's disease antigen (CD30) Proc Natl Acad Sci USA 101 13879 13884 10.1073/pnas.0305789101 1:CAS:528: DC%2BD2cXotVygtbk%3D 15356338 (Pubitemid 39298501)
4. JJ Buza SC Burgess 2007 Modeling the proteome of a Marek's disease transformed cell line: a natural animal model for CD30 overexpressing lymphomas Proteomics 7 1316 1326 10.1002/pmic.200600946 1:CAS:528:DC%2BD2sXlsVWqur0%3D 17443643 (Pubitemid 46722454)
5. LA Shack JJ Buza SC Burgess 2008 The neoplastically transformed (CD30(hi)) Marek's disease lymphoma cell phenotype most closely resembles T-regulatory cells Cancer Immunol Immunother 57 1253 1262 10.1007/s00262-008- 0460-2 1:STN:280:DC%2BD1czjt1yrsA%3D%3D 18256827
6. SC Burgess TF Davison 2002 Identification of the neoplastically transformed cells in Marek's disease herpesvirus-induced lymphomas: recognition by the monoclonal antibody AV37 J Virol 76 7276 7292 10.1128/JVI.76.14.7276- 7292.2002 1:CAS:528:DC%2BD38XltVylsLw%3D 12072527
7. AS Abdelrazeq 2007 Spontaneous regression of colorectal cancer: a review of cases from 1900 to 2005 Int J Colorectal Dis 22 727 736 10.1007/s00384-006- 0245-z 17146588 (Pubitemid 46863749)
8. SC Burgess BH Basaran TF Davison 2001 Resistance to Marek's disease herpesvirus-induced lymphoma is multiphasic and dependent on host genotype Vet Pathol 38 129 142 10.1354/vp.38-2-129 1:STN:280:DC%2BD3M7ovVKluw%3D%3D 11280369 (Pubitemid 33621689)
9. Burgess SC, Venugopal KN (2002) Chapter VII: Anti-tumor immune responses after infection with the Marek's disease and Avian Leukosis Oncogenic viruses of poultry. In: Mathew T (ed) Advances in medical & veterinary virology, immunology and epidemiology modern concepts of immunology in veterinary medicine: poultry immunology. Thajema, West Orange, NJ, USA, pp 236-291
10. A O'Garra N Arai 2000 The molecular basis of T helper 1 and T helper 2 cell differentiation Trends Cell Biol 10 542 550 10.1016/S0962-8924(00)01856-0 11121747 (Pubitemid 30831454)
11. W Hansen K Loser AM Westendorf, et al. 2006 G protein-coupled receptor 83 overexpression in naive CD4+CD25- T cells leads to the induction of Foxp3+ regulatory T cells in vivo J Immunol 177 209 215 1:CAS:528:DC%2BD28XlvV2nsLc%3D 16785516
12. AG Jarnicki J Lysaght S Todryk, et al. 2006 Suppression of antitumor immunity by IL-10 and TGF-beta-producing T cells infiltrating the growing tumor: influence of tumor environment on the induction of CD4+ and CD8+ regulatory T cells J Immunol 177 896 904 1:CAS:528:DC%2BD28XmsVartr8%3D 16818744
13. S Pfoertner A Jeron M Probst-Kepper, et al. 2006 Signatures of human regulatory T cells: an encounter with old friends and new players Genome Biol 7 R54 10.1186/gb-2006-7-7-r54 16836768 (Pubitemid 44237023)
14. D Kabelitz D Wesch HH Oberg 2006 Regulation of regulatory T cells: role of dendritic cells and toll-like receptors Crit Rev Immunol 26 291 306 1:CAS:528:DC%2BD28Xht12mtbvJ 17073555
15. H Liu BP Leung 2006 CD4+CD25+ regulatory T cells in health and disease Clin Exp Pharmacol Physiol 33 519 524 10.1111/j.1440-1681.2006.04401.x 1:CAS:528:DC%2BD28XlvFCmt78%3D 16700888 (Pubitemid 43909341)
16. T Mizobuchi K Yasufuku Y Zheng, et al. 2003 Differential expression of Smad7 transcripts identifies the CD4+CD45RChigh regulatory T cells that mediate type V collagen-induced tolerance to lung allografts J Immunol 171 1140 1147 1:CAS:528:DC%2BD3sXlsFymtb8%3D 12874199
17. S Dominitzki MC Fantini C Neufert, et al. 2007 Cutting edge: trans-signaling via the soluble IL-6R abrogates the induction of FoxP3 in naive CD4+CD25 T cells J Immunol 179 2041 2045 1:CAS:528:DC%2BD2sXosVyrtbY%3D 17675459
18. L Rothwell JR Young R Zoorob, et al. 2004 Cloning and characterization of chicken IL-10 and its role in the immune response to Eimeria maxima J Immunol 173 2675 2682 1:CAS:528:DC%2BD2cXmt1Oksrs%3D 15294985
19. MG Kaiser JH Cheeseman P Kaiser, et al. 2006 Cytokine expression in chicken peripheral blood mononuclear cells after in vitro exposure to Salmonella enterica serovar Enteritidis Poult Sci 85 1907 1911 1:CAS:528: DC%2BD28Xht1WjsLfL 17032822
20. P Kaiser G Underwood F Davison 2003 Differential cytokine responses following Marek's disease virus infection of chickens differing in resistance to Marek's disease J Virol 77 762 768 10.1128/JVI.77.1.762-768.2003 1:CAS:528:DC%2BD3sXkt1Ol 12477883 (Pubitemid 36005017)
21. I Eldaghayes L Rothwell A Williams, et al. 2006 Infectious bursal disease virus: strains that differ in virulence differentially modulate the innate immune response to infection in the chicken bursa Viral Immunol 19 83 91 10.1089/vim.2006.19.83 1:CAS:528:DC%2BD28Xis1GrtrY%3D 16553553
22. FM McCarthy SM Bridges SC Burgess 2007 Going from functional genomics to biological significance Cytogenet Genome Res 117 278 287 10.1159/000103189 1:CAS:528:DC%2BD2sXosFKitrw%3D 17675869 (Pubitemid 47202688)
23. KA Schat Z Xing 2000 Specific and nonspecific immune responses to Marek's disease virus Dev Comp Immunol 24 201 221 10.1016/S0145-305X(99)00073-7 1:CAS:528:DC%2BD3cXisleisLg%3D 10717288 (Pubitemid 30136301)
24. Z Xing KA Schat 2000 Inhibitory effects of nitric oxide and gamma interferon on in vitro and in vivo replication of Marek's disease virus J Virol 74 3605 3612 10.1128/JVI.74.8.3605-3612.2000 1:CAS:528:DC%2BD3cXitFOlsLc%3D 10729136 (Pubitemid 30180304)
25. Z Xing KA Schat 2000 Expression of cytokine genes in Marek's disease virus-infected chickens and chicken embryo fibroblast cultures Immunology 100 70 76 10.1046/j.1365-2567.2000.00008.x 1:CAS:528:DC%2BD3cXjsVaju7s%3D 10809961 (Pubitemid 30242884)
26. MF Abdul-Careem BD Hunter P Parvizi, et al. 2007 Cytokine gene expression patterns associated with immunization against Marek's disease in chickens Vaccine 25 424 432 10.1016/j.vaccine.2006.08.006 1:CAS:528:DC%2BD28Xht12ru7%2FF 17070626 (Pubitemid 44856099)
27. P Quere C Rivas K Ester, et al. 2005 Abundance of IFN-alpha and IFN-gamma mRNA in blood of resistant and susceptible chickens infected with Marek's disease virus (MDV) or vaccinated with turkey herpesvirus; and MDV inhibition of subsequent induction of IFN gene transcription Arch Virol 150 507 519 10.1007/s00705-004-0435-3 1:CAS:528:DC%2BD2MXhvVSqsbo%3D 15592893 (Pubitemid 40383683)
28. Heidari M, Zhang HM, Sharif S (2008) Marek's disease virus induces Th-2 activity during Cytolytic Infection. Viral Immunol
29. PA Antony NP Restifo 2005 CD4+CD25+ T regulatory cells, immunotherapy of cancer, and interleukin-2 J Immunother 28 120 128 10.1097/01.cji.0000155049. 26787.45 1:CAS:528:DC%2BD2MXhsFSmurg%3D 15725955
30. AM Levy Y Izumiya P Brunovskis, et al. 2003 Characterization of the chromosomal binding sites and dimerization partners of the viral oncoprotein Meq in Marek's disease virus-transformed T cells J Virol 77 12841 12851 10.1128/JVI.77.23.12841-12851.2003 1:CAS:528:DC%2BD3sXptFOjsLc%3D 14610205 (Pubitemid 37430678)
31. LF Lu MA Gavin JP Rasmussen, et al. 2007 G protein-coupled receptor 83 is dispensable for the development and function of regulatory T cells Mol Cell Biol 27 8065 8072 10.1128/MCB.01075-07 1:CAS:528:DC%2BD2sXhsVeis7bK 17893329 (Pubitemid 350234223)
32. K Miyazono P ten Dijke CH Heldin 2000 TGF-beta signaling by Smad proteins Adv Immunol 75 115 157 10.1016/S0065-2776(00)75003-6 1:CAS:528: DC%2BD3cXltFSru7c%3D 10879283
33. YP Rubtsov AY Rudensky 2007 TGFbeta signalling in control of T-cell-mediated self-reactivity Nat Rev Immunol 7 443 453 10.1038/nri2095 1:CAS:528:DC%2BD2sXls1Kgt78%3D 17525753 (Pubitemid 46834850)
34. J Marx 2004 Cancer research Inflammation and cancer: the link grows stronger. Science 306 966 968 1:CAS:528:DC%2BD2cXpsF2ht74%3D
35. GL Hold ME El-Omar 2008 Genetic aspects of inflammation and cancer Biochem J 410 225 235 10.1042/BJ20071341 1:CAS:528:DC%2BD1cXhvVymsb0%3D 18254728 (Pubitemid 351346180)
36. T Okamoto T Sanda K Asamitsu 2007 NF-kappa B signaling and carcinogenesis Curr Pharm Des 13 447 462 10.2174/138161207780162944 1:CAS:528: DC%2BD2sXjvVylt78%3D 17348842 (Pubitemid 46477750)
37. R Horie T Watanabe 1998 CD30: expression and function in health and disease Semin Immunol 10 457 470 10.1006/smim.1998.0156 1:CAS:528: DyaK1MXktFOnsQ%3D%3D 9826579 (Pubitemid 28564375)
38. B Herreros A Sanchez-Aguilera MA Piris 2008 Lymphoma microenvironment: culprit or innocent? Leukemia 22 49 58 10.1038/sj.leu.2404970 1:STN:280:DC%2BD1c%2Fkt1KktQ%3D%3D 17914412
39. BF Skinnider TW Mak 2002 The role of cytokines in classical Hodgkin lymphoma Blood 99 4283 4297 10.1182/blood-2002-01-0099 1:CAS:528: DC%2BD38XksFGlu74%3D 12036854 (Pubitemid 34627193)
40. O Cochet C Frelin JF Peyron, et al. 2006 Constitutive activation of STAT proteins in the HDLM-2 and L540 Hodgkin lymphoma-derived cell lines supports cell survival Cell Signal 18 449 455 10.1016/j.cellsig.2005.05.010 1:CAS:528:DC%2BD2MXhtlags73P 15967637 (Pubitemid 41790365)
41. K Jurianz P von Hoegen V Schirrmacher 1999 Immunological and molecular characterization of an aggressive murine lymphoma variant: modulation in vitro and in vivo Int J Oncol 15 71 79 1:CAS:528:DyaK1MXkt1egsrg%3D 10375596
42. Foster AE, Dotti G, Lu A et al (2008) Antitumor activity of EBV-specific T lymphocytes transduced with a dominant negative TGF-beta receptor. J Immunother
43. Baumforth KR, Birgersdotter A, Reynolds GM et al (2008) Expression of the Epstein-Barr Virus-Encoded Epstein-Barr Virus Nuclear Antigen 1 in Hodgkin's Lymphoma Cells Mediates Up-Regulation of CCL20 and the Migration of Regulatory T Cells. Am J Pathol
44. T Alvaro M Lejeune JF Garcia, et al. 2008 Tumor-infiltrated immune response correlates with alterations in the apoptotic and cell cycle pathways in Hodgkin and Reed-Sternberg cells Clin Cancer Res 14 685 691 10.1158/1078-0432.CCR-07-1246 1:CAS:528:DC%2BD1cXhsFyktr4%3D 18245527 (Pubitemid 351231148)
45. T Alvaro M Lejeune MT Salvado, et al. 2006 Immunohistochemical patterns of reactive microenvironment are associated with clinicobiologic behavior in follicular lymphoma patients J Clin Oncol 24 5350 5357 10.1200/JCO.2006.06.4766 17135637 (Pubitemid 46623165)
46. BE Wahlin B Sander B Christensson, et al. 2007 CD8+ T-cell content in diagnostic lymph nodes measured by flow cytometry is a predictor of survival in follicular lymphoma Clin Cancer Res 13 388 397 10.1158/1078-0432.CCR-06-1734 1:CAS:528:DC%2BD2sXoslSmsA%3D%3D 17255259 (Pubitemid 46225341)
47. K Chamoto A Kosaka T Tsuji, et al. 2003 Critical role of the Th1/Tc1 circuit for the generation of tumor-specific CTL during tumor eradication in vivo by Th1-cell therapy Cancer Sci 94 924 928 10.1111/j.1349-7006.2003.tb01377. x 1:CAS:528:DC%2BD3sXpsFGhtb8%3D 14556668 (Pubitemid 37406977)